Ungerechts, G <br/><br/>
Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics.  [electronic resource] 

 -  Gene therapy  Dec 2010 
 - 1506-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5462 
<br/><br/><label>Standard No.: </label>10.1038/gt.2010.103  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD20--metabolism<br/>Antineoplastic Agents--therapeutic use<br/>Cells, Cultured<br/>Chlorocebus aethiops<br/>Cyclophosphamide--therapeutic use<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lymphoma, Mantle-Cell--drug therapy<br/>Measles virus--genetics<br/>Mice<br/>Mice, SCID<br/>Molecular Targeted Therapy<br/>Oncolytic Viruses--genetics<br/>Salvage Therapy<br/>Tumor Burden--drug effects<br/>Vero Cells<br/>Vidarabine--analogs & derivatives<br/>Xenograft Model Antitumor Assays